These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37143609)

  • 1. A novel echocardiographic risk score for light-chain amyloidosis.
    Geenty P; Sivapathan S; Stefani LD; Zada M; Boyd A; Richards D; Kwok F; Thomas L
    Eur Heart J Open; 2023 May; 3(3):oead040. PubMed ID: 37143609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of left atrial mechanics in cardiac light-chain amyloidosis with preserved ejection fraction: a cohort study.
    Liu XH; Shi JY; Zhang DD; Jia FW; Lin X; Zhu YL; Zhuang JL; Fang LG; Chen W
    BMC Cardiovasc Disord; 2022 Apr; 22(1):175. PubMed ID: 35428181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
    Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
    J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial function in patients with light chain amyloidosis: A transthoracic 3D speckle tracking imaging study.
    Mohty D; Petitalot V; Magne J; Fadel BM; Boulogne C; Rouabhia D; El Hamel C; Lavergne D; Damy T; Aboyans V; Jaccard A
    J Cardiol; 2018 Apr; 71(4):419-427. PubMed ID: 29153741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis.
    Bak M; Kim D; Choi JO; Kim K; Kim SJ; Jeon ES
    Front Cardiovasc Med; 2022; 9():904878. PubMed ID: 35811735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
    Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
    J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
    Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
    Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.
    Huntjens PR; Zhang KW; Soyama Y; Karmpalioti M; Lenihan DJ; Gorcsan J
    JACC Cardiovasc Imaging; 2021 Aug; 14(8):1508-1519. PubMed ID: 33744146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.
    Milani P; Dispenzieri A; Scott CG; Gertz MA; Perlini S; Mussinelli R; Lacy MQ; Buadi FK; Kumar S; Maurer MS; Merlini G; Hayman SR; Leung N; Dingli D; Klarich KW; Lust JA; Lin Y; Kapoor P; Go RS; Pellikka PA; Hwa YL; Zeldenrust SR; Kyle RA; Rajkumar SV; Grogan M
    Circ Cardiovasc Imaging; 2018 May; 11(5):e006588. PubMed ID: 29752392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial structure and function in cardiac amyloidosis.
    Nochioka K; Quarta CC; Claggett B; Roca GQ; Rapezzi C; Falk RH; Solomon SD
    Eur Heart J Cardiovasc Imaging; 2017 Oct; 18(10):1128-1137. PubMed ID: 28637305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in left ventricular and atrial mechanics and function after dialysis in patients with end-stage renal disease.
    Wang X; Hong J; Zhang T; Xu D
    Quant Imaging Med Surg; 2021 May; 11(5):1899-1908. PubMed ID: 33936973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular function in AL amyloidosis: characteristics and prognostic implication.
    Cappelli F; Porciani MC; Bergesio F; Perlini S; Attanà P; Moggi Pignone A; Salinaro F; Musca F; Padeletti L; Perfetto F
    Eur Heart J Cardiovasc Imaging; 2012 May; 13(5):416-22. PubMed ID: 22180463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Cardiac Recovery and Hematologic Response to Chemotherapy in Patients With Light-Chain Amyloidosis (from the Stanford University Amyloidosis Registry).
    Tuzovic M; Kobayashi Y; Wheeler M; Barrett C; Liedtke M; Lafayette R; Schrier S; Haddad F; Witteles R
    Am J Cardiol; 2017 Oct; 120(8):1381-1386. PubMed ID: 28844519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time trajectory of cardiac function and its relation with survival in patients with light-chain cardiac amyloidosis.
    Hwang IC; Koh Y; Park JB; Yoon YE; Kim HL; Kim HK; Kim YJ; Cho GY; Sohn DW; Lee SP
    Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):459-469. PubMed ID: 32533163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial remodeling and the prognostic value of feature tracking derived left atrial strain in patients with light-chain amyloidosis: a cardiovascular magnetic resonance study.
    Tan Z; Yang Y; Wu X; Li S; Li L; Zhong L; Lin Q; Fei H; Liao P; Wang W; Liu H
    Int J Cardiovasc Imaging; 2022 Jul; 38(7):1519-1532. PubMed ID: 35113283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.
    Yue X; Yang L; Wang R; Chan Q; Yang Y; Wu X; Ruan X; Zhang Z; Wei Y; Wang F
    Front Cardiovasc Med; 2022; 9():1017097. PubMed ID: 36330005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.